Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001780 |
---|---|
Receipt number | R000002146 |
Scientific Title | Phase I/II study of intermittent erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer |
Date of disclosure of the study information | 2009/03/17 |
Last modified on | 2019/07/17 16:08:55 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/03/17 18:13:01 | ||
2 | Update | 2009/05/19 16:26:50 | Recruitment status |
|
3 | Update | 2009/12/21 17:02:28 | Recruitment status |
|
4 | Update | 2010/03/17 09:15:23 | Last follow-up date |
|
5 | Update | 2010/09/17 09:31:35 | Name of person sending information |
|
6 | Update | 2011/06/01 11:36:22 | Primary outcomes Key secondary outcomes Key secondary outcomes |
|
7 | Update | 2011/06/01 16:20:09 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
8 | Update | 2015/02/21 12:34:54 | Recruitment status Last follow-up date |
|
9 | Update | 2019/01/29 18:06:09 | Recruitment status Publication of results |
|
10 | Update | 2019/07/17 16:07:42 | Publication of results URL related to results and publications Number of participants that the trial has enrolled |
|
11 | Update | 2019/07/17 16:08:55 | Recruitment status Date of IRB Last follow-up date |